Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls

Delorme, Richard ; Scheid, Isabelle ; Anckarsäter, Henrik LU ; Chaste, Pauline ; Jamain, Stephane ; Schuroff, Franck ; Nygren, Gudrun ; Herbrecht, Evelyn ; Dumaine, Anne and Mouren, Marie Christine , et al. (2010) In BMC Med Genet 11(1:108).
Abstract
BACKGROUND: The gene encoding carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase (NOS1AP) is located on chromosome 1q23.3, a candidate region for schizophrenia, autism spectrum disorders (ASD) and obsessive-compulsive disorder (OCD). Previous genetic and functional studies explored the role of NOS1AP in these psychiatric conditions, but only a limited number explored the sequence variability of NOS1AP. METHODS: We analyzed the coding sequence of NOS1AP in a large population (n=280), including patients with schizophrenia (n=72), ASD (n=81) or OCD (n=34), and in healthy volunteers controlled for the absence of personal or familial history of psychiatric disorders (n=93). RESULTS: Two non-synonymous variations, V37I and D423N were... (More)
BACKGROUND: The gene encoding carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase (NOS1AP) is located on chromosome 1q23.3, a candidate region for schizophrenia, autism spectrum disorders (ASD) and obsessive-compulsive disorder (OCD). Previous genetic and functional studies explored the role of NOS1AP in these psychiatric conditions, but only a limited number explored the sequence variability of NOS1AP. METHODS: We analyzed the coding sequence of NOS1AP in a large population (n=280), including patients with schizophrenia (n=72), ASD (n=81) or OCD (n=34), and in healthy volunteers controlled for the absence of personal or familial history of psychiatric disorders (n=93). RESULTS: Two non-synonymous variations, V37I and D423N were identified in two families, one with two siblings with OCD and the other with two brothers with ASD. These rare variations apparently segregate with the presence of psychiatric conditions. CONCLUSIONS: Coding variations of NOS1AP are relatively rare in patients and controls. Nevertheless, we report the first non-synonymous variations within the human NOS1AP gene that warrant further genetic and functional investigations to ascertain their roles in the susceptibility to psychiatric disorders. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
BMC Med Genet
volume
11
issue
1:108
publisher
BioMed Central (BMC)
external identifiers
  • scopus:77954166772
  • pmid:20602773
DOI
10.1186/1471-2350-11-108
language
English
LU publication?
yes
id
7f088384-604a-4a0a-b056-5e7e33d48504 (old id 1627794)
date added to LUP
2016-04-04 10:47:09
date last changed
2022-03-15 22:16:16
@article{7f088384-604a-4a0a-b056-5e7e33d48504,
  abstract     = {{BACKGROUND: The gene encoding carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase (NOS1AP) is located on chromosome 1q23.3, a candidate region for schizophrenia, autism spectrum disorders (ASD) and obsessive-compulsive disorder (OCD). Previous genetic and functional studies explored the role of NOS1AP in these psychiatric conditions, but only a limited number explored the sequence variability of NOS1AP. METHODS: We analyzed the coding sequence of NOS1AP in a large population (n=280), including patients with schizophrenia (n=72), ASD (n=81) or OCD (n=34), and in healthy volunteers controlled for the absence of personal or familial history of psychiatric disorders (n=93). RESULTS: Two non-synonymous variations, V37I and D423N were identified in two families, one with two siblings with OCD and the other with two brothers with ASD. These rare variations apparently segregate with the presence of psychiatric conditions. CONCLUSIONS: Coding variations of NOS1AP are relatively rare in patients and controls. Nevertheless, we report the first non-synonymous variations within the human NOS1AP gene that warrant further genetic and functional investigations to ascertain their roles in the susceptibility to psychiatric disorders.}},
  author       = {{Delorme, Richard and Scheid, Isabelle and Anckarsäter, Henrik and Chaste, Pauline and Jamain, Stephane and Schuroff, Franck and Nygren, Gudrun and Herbrecht, Evelyn and Dumaine, Anne and Mouren, Marie Christine and Råstam, Maria and Leboyer, Marion and Gillberg, Christopher and Bourgeron, Thomas}},
  language     = {{eng}},
  number       = {{1:108}},
  publisher    = {{BioMed Central (BMC)}},
  series       = {{BMC Med Genet}},
  title        = {{Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls}},
  url          = {{http://dx.doi.org/10.1186/1471-2350-11-108}},
  doi          = {{10.1186/1471-2350-11-108}},
  volume       = {{11}},
  year         = {{2010}},
}